Literature DB >> 34011888

Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.

.   

Abstract

Uterine leiomyomas (fibroids) are the most common solid and symptomatic neoplasm in women. They are the leading indication for hysterectomy (1, 2), which is a definitive and effective surgical treatment for leiomyoma. However, many patients benefit from and seek out management options other than hysterectomy because they desire future childbearing or wish to retain their uterus. The purpose of this Practice Bulletin is to provide updated evidence-based recommendations for the medical, procedural, and surgical management of symptomatic leiomyomas. Discussion of the use of morcellation in the surgical management of leiomyomas is beyond the scope of this document and is addressed in a separate American College of Obstetricians and Gynecologists (ACOG) publication (3).
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34011888     DOI: 10.1097/AOG.0000000000004401

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Uterine Fibroids: Hiding in Plain Sight.

Authors:  Elizabeth A Stewart; Romana A Nowak
Journal:  Physiology (Bethesda)       Date:  2022-01-01

2.  Route of myomectomy and fertility: a prospective cohort study.

Authors:  Lauren A Wise; Laine Thomas; Sophia Anderson; Donna D Baird; Raymond M Anchan; Kathryn L Terry; Erica E Marsh; Ganesa Wegienka; Wanda Kay Nicholson; Kedra Wallace; Robert Bigelow; James Spies; George L Maxwell; Vanessa Jacoby; Evan R Myers; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2022-02-23       Impact factor: 7.490

3.  Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.

Authors:  Quaker E Harmon; Stacy A Patchel; Shanshan Zhao; David M Umbach; Tracy E Cooper; Donna D Baird
Journal:  Obstet Gynecol       Date:  2022-04-05       Impact factor: 7.623

4.  Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System.

Authors:  Ladina Christoffel; Ralf Bends; David Toub; Sven Schiermeier; Gregor Pschadka; Matthias Engelhardt; Stephen Quinn; Michael Hartmann; Marwan Habiba; Ricardo Felberbaum; Anke Brössner; Cordula Schippert; Thomas Römer
Journal:  J Gynecol Surg       Date:  2022-06-13

5.  Pressure-Induced Fibroid Ischemia: First-In-Human Experience with a Novel Device for Laparoscopic Treatment of Symptomatic Uterine Fibroids.

Authors:  Michael G Tal; Ran Keidar; Gilad Magnazi; Ohad Henn; Jin Hee Kim; Scott G Chudnoff; Kevin J Stepp
Journal:  Reprod Sci       Date:  2022-08-08       Impact factor: 2.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.